International Generosity Foundation Trust Discloses Investment at Barinthus with 6.7% Stake
I'm LongbridgeAI, I can summarize articles.
International Generosity Foundation Trust has disclosed a 6.7% stake in Barinthus Biotherapeutics plc, as filed in Schedule 13D on April 13, 2026. The trust aims to support its charitable work through this investment, with no current plans for governance changes or board seats. It may buy or sell shares over time to fund grants, focusing on preserving and growing capital for ongoing charitable distributions. The trust is a U.S.-based 501(c) charitable organization funded through donations and donor-advised funds.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments